Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An epithelial neoplasm arising from the thymus. It may be associated with myasthenia gravis, pure red cell aplasia, and hypogammaglobulinemia. It includes thymoma type B1 which is a thymoma of low grade malignant potential, thymoma type B2 which is a thymoma of moderate malignancy, and thymoma type B3 which is also known as well differentiated thymic carcinoma.
Biomarker and diagnostic research for thymoma type B has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for thymoma type B.
13 publications have been identified in PubMed for thymoma type B. Research spans Basic Science / Preclinical (31%), Gene Therapy / Novel Therapeutics (23%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 4 | 31% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 5:02 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
3 |
23% |
Disease patterns and progression | 2 | 15% |
Testing and diagnosis research | 1 | 8% |
Research summaries | 1 | 8% |
Patient case studies | 1 | 8% |
Clinical study results | 1 | 8% |
Ida A (2026). [PMID: 42098011](https://pubmed.ncbi.nlm.nih.gov/42098011/). *Kyobu Geka*. [Case Report / Case Series]
Fu Z (2026). [PMID: 41979632](https://pubmed.ncbi.nlm.nih.gov/41979632/). *Clin Lab*. [Basic Science / Preclinical]
Liu W (2026). [PMID: 41691589](https://pubmed.ncbi.nlm.nih.gov/41691589/). *Discover oncology*. [Epidemiology / Natural History]
Chanalia V (2026). [PMID: 41928685](https://pubmed.ncbi.nlm.nih.gov/41928685/). *Protein Pept Lett*. [Gene Therapy / Novel Therapeutics]
Parmar K (2025). [PMID: 41503579](https://pubmed.ncbi.nlm.nih.gov/41503579/). *Mediastinum (Hong Kong, China)*. [Review / Meta-Analysis]
Yu XT (2025). [PMID: 40328968](https://pubmed.ncbi.nlm.nih.gov/40328968/). *Genes and immunity*. [Gene Therapy / Novel Therapeutics]
Wang J (2025). [PMID: 39948171](https://pubmed.ncbi.nlm.nih.gov/39948171/). *Nature biomedical engineering*. [Basic Science / Preclinical]
Kawaguchi Y (2025). [PMID: 39788395](https://pubmed.ncbi.nlm.nih.gov/39788395/). *International journal of pharmaceutics*. [Gene Therapy / Novel Therapeutics]
Du X (2025). [PMID: 41044692](https://pubmed.ncbi.nlm.nih.gov/41044692/). *BMC cancer*. [Diagnostic / Biomarker]
Jin Y (2025). [PMID: 39171951](https://pubmed.ncbi.nlm.nih.gov/39171951/). *Autophagy*. [Basic Science / Preclinical]
AI-curated news mentioning thymoma type B
Updated Aug 26, 2026
Recent research highlights a link between thymoma-related autoimmunity and cases of fulminant myocarditis leading to sudden death. This study underscores the need for increased awareness and monitoring of cardiac complications in patients with thymoma.
A recent study highlights an unexpected decline in pulmonary function in a patient with thymoma, which was initially misdiagnosed as obstructive bronchiolitis. This case underscores the need for careful evaluation of pulmonary symptoms in patients with thymoma.
A nationwide analysis in Japan from 2018 to 2022 reveals treatment practices for advanced thymoma and advanced thymic carcinoma. This study provides insights into evolving therapeutic approaches for these rare tumors.